BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The findings from studies of BCR-ABLp210 transformation, which led to CML in the transgenic mice, indicate that the action of the oncogenes in setting the lineage fate of the leukemia cells is by virtue of epigenetic reprogramming.